CatalystWireBeta

Response To Revised Possible Offer Announcement

In brief · summary, not quotable

MISSION Group rejects revised all-share takeover offer from Brave Bison valuing shares at 35 pence.

  • Revised offer valuation per MISSION share 35 pence
  • Exchange ratio 13.9 Brave Bison shares per MISSION share
  • MISSION shareholder holding in combined group approximately 50 per cent.
  • MISSION revenue contribution to combined group approximately 81 per cent.
  • MISSION adjusted EBITDA contribution approximately 71 per cent.
  • Proposed equity fundraising £10-15 million
Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your BBSN notes

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY OFFER WILL BE MADE

The MISSION Group plc

("MISSION", the "Company" or the "Group")

RESPONSE TO REVISED POSSIBLE OFFER ANNOUNCEMENT BY BRAVE BISON GROUP PLC

MISSION Group plc (AIM: TMG), notes the announcement released on 3 June 2024 by Brave Bison Group plc ("Brave Bison") in accordance with Rule 2.4 of the City Code on Takeovers and Mergers (the "Code") and confirms, in line with the announcement it made on 4 June 2024, that on 25 May 2024, it received a further unsolicited conditional proposal regarding a possible offer by Brave Bison for the entire issued and to be issued share capital of MISSION. Such possible offer comprised an all-share offer at an exchange ratio of 13.9 Brave Bison shares for each ordinary share in MISSION, a partial cash alternative of up to 50 per cent. of the potential offer price and the intention to undertake an underwritten share placing to reduce indebtedness of the proposed combined group (the "Revised Possible Offer").

The board of MISSION ("Board") understands that the amount of such partial cash alternative and the quantum of any proposed reduction in indebtedness for the proposed combined group is not certain and will be determined by Brave Bison following a period of due diligence.

Based on the terms of the Revised Possible Offer and the closing market prices of MISSION and Brave Bison shares on 10 May 2024, being the last trading day prior to Brave Bison's 12 May 2024 announcement of the initial possible offer, the Revised Possible Offer values each MISSION share at approximately 35 pence1. Were the Revised Possible Offer to be implemented on its indicative terms, prior to any proposed equity fundraising, this would result in MISSION's shareholders holding approximately 50 per cent. of the proposed combined group.

On 6 June 2024, the Board of MISSION, following consultation with its financial advisers and a period of engagement with certain of its shareholders, unanimously rejected the Revised Possible Offer which it believes to be opportunistic and undervalues the Group and its prospects. Moreover, it is dilutive to MISSION's shareholders as it does not reflect the relevant contributions of each party to the proposed combined group.

In that regard, the Board of MISSION would like to bring shareholders' attention to the following points:

  • The Board continues to believe that the Revised Possible Offer does not fully reflect the inherent value in MISSION which, has been reflected in a 62.1 per cent. increase in the MISSION share price to 10 May 20243.
  • Moreover, the Board believes that the Revised Possible Offer undervalues the contribution of MISSION to the proposed combined group. Based on the respective net revenue, adjusted EBITDA and adjusted pre-tax profit contributions of MISSION and Brave Bison as set out in their respective results for their financial years ending 31 December 2023, MISSION would contribute approximately 81 per cent. of revenues, approximately 71 per cent. of adjusted EBITDA and approximately 54 per cent. of adjusted pre-tax profits to the proposed combined group2. The proposed exchange ratio under the terms of the Revised Possible Offer and of MISSION's shareholders holding approximately 50 per cent. of the proposed combined group does not reflect that contribution.
  • The proposed holding by MISSION shareholders of approximately 50 per cent. of the proposed combined group also only represents the position before any potential dilution from the proposed equity fundraising outlined by Brave Bison in its 3 June possible offer announcement. The Board of MISSION understands that, while subject to due diligence, the size of this fundraising is anticipated to be between £10 - 15 million at a price of 2.53 pence per Brave Bison share. Brave Bison has indicated to MISSION that the proceeds of the equity fundraising, together with Brave Bison's existing cash (approximately £7 million at 31 December 2023), would be used to deleverage the proposed combined group and to satisfy a cash alternative of up to 17.5 pence per MISSION share. Brave Bison's current assumption based on publicly available information is that a minimum of £4 million and a maximum of £10 million would be required to reduce indebtedness, therefore providing between £10 million and £16 million for a cash alternative. The effect of any such equity fundraising could therefore further dilute MISSION's shareholders' interest in the proposed combined group below the proposed approximately 50 per cent. holding to the extent that MISSION's shareholders did not or were not able to participate in such fundraising.
  • Brave Bison has indicated the proposed equity fundraising would be underwritten by Oliver and Theodore Green and certain Brave Bison shareholders.
  • Brave Bison's proposed Board composition under the terms of the Revised Possible Offer also currently envisage only two additional Non-Executive Directors and no executive directors from MISSION joining the board of the proposed combined group. In the Board's view this does not reflect the significant contribution of MISSION to the proposed combined group.
  • The Board of MISSION continues to believe the Revised Possible Offer is not transformational for MISSION and its offering to its clients. The increased scale and some additional capabilities do not offset the dilutive impact to MISSION's shareholders of only holding approximately 50 per cent. of the proposed combined group and potentially less following the proposed equity fundraising. The MISSION directors also believe that the Revised Possible Offer does not provide a step change in scale, nor any new offering or access to new markets. In addition, in the meetings between Brave Bison and MISSION management, the MISSION management does not believe that Brave Bison have set out a compelling future strategy for the proposed combined group.
  • Notwithstanding the proposed dilution referred to above, Brave Bison anticipates that MISSION's shareholders would enjoy more value from the combination based on a re-rating of the proposed combined group. There is no certainty of a re-rating. In addition, if Brave Bison's shares are re-rated, it is likely this will benefit Brave Bison shareholders more than MISSION shareholders. This is because the current exchange ratio does not reflect the contribution of the MISSION business to the proposed combined group. Furthermore, following the proposed placing, MISSION shareholders may not continue to hold approximately 50 per cent. of the proposed combined group.
  • As previously announced on 17 January 2024, the Board of MISSION has set out how it expects to realise value for MISSION's shareholders through its standalone strategy and execution of the Group's Value Restoration Plan, which is now well underway.
  • The Board continues to work closely with NatWest, the Company's lender, and was pleased to announce a refinancing arrangement on 28 March 2024, which extended facilities through to 5 April 2026. This provides the flexibility the Company needs to deliver on its Value Restoration Plan and reduce its leverage.
  • In addition, the Board of MISSION continues to review the Group's options to reduce its debt position, including the disposal of certain assets within its portfolio. MISSION is in active discussions on a number of these assets. The Board considers that an disposal of even some of the assets would have a material impact on deleveraging, based on the estimated proceeds. The Board of MISSION remains confident that during the remainder of the year, it will deliver on its plan to reduce leverage.
  • The announcement by Brave Bison on 3 June 2024 in relation to the Revised Possible Offer stated that MISSION's net debt was £25.5 million as at 20 October 2023, £25.2 million as at 31 December 2023 and £26.8 million as at 30 April 2024. The Board of MISSION wishes to advise that the net debt balance stated by Brave Bison in this announcement in relation to 20 October 2023 excludes acquisition obligations, while the balances at 31 December 2023 and 30 April 2024 include acquisition obligations. The net debt as at 20 October 2023 (including acquisition obligations) was £31.0 million, compared to £25.2 million at 31 December 2023 and £26.8 million as at 30 April 2024 on the same basis, representing a reduction of £4.2 million. MISSION also wishes to clarify that the Pathfindr £1 million initial consideration was received in the financial year ended 31 December 2023.
  • The Board of MISSION notes that Tangent Marketing Services Limited ("Tangent") is referenced in Brave Bison's annual report as a related party of Brave Bison as Oliver and Theodore Green are indirect shareholders of Tangent, and Tangent is co-located with Brave Bison in its London offices. It is unclear to MISSION whether Tangent operates in a similar market segment to Brave Bison and/or MISSION, and/or what ongoing time commitments Brave Bison management have with Tangent.

As previously announced, the Board of MISSION is open to proposals that it believes would enhance shareholder value and deliver benefits to MISSION's shareholders. The Board of MISSION does not consider the terms of the Revised Possible Offer to meet those criteria.

Shareholders are urged to take no further action at this time.

In accordance with Rule 2.6(a) of the Code, Brave Bison must, by no later than 5.00 p.m. (London time) on 9 June 2024, either announce a firm intention to make an offer for MISSION in accordance with Rule 2.7 of the Code, or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. The deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.

This announcement has been made by MISSION without the agreement or approval of Brave Bison.

There can be no certainty either that an offer will be made.

The attention of shareholders is drawn to the disclosure requirements of Rule 8 of the Code, which are summarised below.

Footnotes:

1 The valuation of approximately 35.2 pence per MISSON share for MISSION's shareholders in the proposed combined group, is based on (i) an exchange ratio of 13.9 Brave Bison shares for each ordinary share in MISSION, (ii) a Brave Bison closing mid-market share price of 2.525 pence (as at 10 May 2024, being the last trading day prior to Brave Bison's 12 May 2024 announcement of the possible offer), (iii) an issued share capital of MISSION being 92,238,119 shares and a fully diluted share capital of 92,498,311, and (iv) an issued share capital of Brave Bison being 1,288,147,280 shares.

2 The contribution of MISSION to the proposed combined group is based on the following information:

Revenue£ million%
MISSION (see Note 2(a))86.380.5
Brave Bison (see Note 2(b))20.919.5
Pro forma107.2100.0
Adjusted EBITDA
MISSION (see Note 2(a))10.671.3
Brave Bison (see Note 2(b))4.328.7
Pro forma14.9100.0
Adjusted profit before tax
MISSION (see Note 2(a))4.253.6
Brave Bison (see Note 2(b))3.646.4
Pro forma7.8100.0

(a) for the year ended 31 December 2023, MISSION had reported net revenue of £86.3 million from continuing operations (turnover of £195.4 million less cost of sales of £109.1 million), headline EBITDA of £10.6 million (headline operating profit (continuing operations) of £6.5 million, depreciation of owned tangible assets of £1.2 million, depreciation expense on right of use assets of £2.6 million and amortisation of other intangible assets of £0.4 million) and headline pre-tax profits of £4.2 million (continuing operations). This financial information relating to the Company has been extracted or derived (without any adjustment) from the Company's final results for the year ended 31 December 2023;

  • for the year ended 31 December 2023, Brave Bison reported net revenue of £20.9 million (turnover/billings of £35.7 million less cost of sales of £14.8 million), adjusted EBITDA of £4.3 million and adjusted pre-tax profits of £3.6 million. This financial information relating to Brave Bison has been extracted or derived (without any adjustment) from Brave Bison's final results for the year ended 31 December 2023.;

3 The closing mid-market price for a MISSION share on 23 October 2023 was 14.0 pence, and on 10 May 2024 was 22.7 pence.

4 The statements regarding MISSION's outstanding debts (net of cash balances) and certain liabilities totalling approximately £25.2 million as at 31 December 2023 and comprised of net debt of £15.4 million, acquisition obligations of £5.5 million and HMRC Time to Pay agreement of £4.3 million have been extracted or derived (without any adjustment) from MISSION's final results for the year ended 31 December 2023.

5 The statements regarding MISSION's outstanding debts (net of cash balances) and certain liabilities totalling approximately £26.8 million as at 30 April 2024 and comprised of net bank debt of £22.2 million, acquisition obligations of £4.1 million and HMRC Time to Pay agreement of £0.5 million have been extracted from MISSION's unaudited internal financial information.

6 The statements regarding MISSION's outstanding debts (net of cash balances) and certain liabilities totalling approximately £31.0 million as at 20 October 2023 and comprised of net bank debt of £25.5 million, acquisition obligations of £5.5 million and HMRC Time to Pay agreement of £Nil have been extracted from MISSION's unaudited internal financial information.

David Morgan, Non-Executive Chair James Clifton, Chief Executive Officer Giles Lee, Chief Financial Officer The MISSION Group plcVia Houston

Simon Bridges / Julie Langley / Andrew Potts / Harry Rees

Canaccord Genuity Limited (Financial Adviser, Nominated Adviser and Broker)020 7523 8000
Kate Hoare / Alexander Clelland / India Spencer
HOUSTON (Financial PR and Investor Relations)0204 529 0549

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser and corporate broker exclusively for MISSION and for no one else in connection with the Revised Possible Offer and will not regard any other person as its client in relation to the matters referred to in this announcement and will not be responsible to anyone other than MISSION for providing the protections afforded to clients of Canaccord Genuity Limited, nor for providing advice in relation to the Revised Possible Offer or any other matter referred to in this announcement.

Publication of this announcement

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note